Platforms
Cogience builds AI-enabled platforms that shorten market access engagements. Cogience.Advise, our virtual advisory board, is the flagship platform, with additional tooling in active development.
Cogience.Advise · Virtual advisory board
Asynchronous payer engagement
at global scale.
Works across all disease areas, with features tailored to rare, ultra-rare and orphan drug programmes, where the experts who matter most are few, dispersed and rarely free for live meetings.
How it works
From launch to final report in two to three weeks.
-
01
Curate the panel
Five to ten senior advisors from Cogience's global network: payers, HTA evaluators, KOLs and patient advocates.
-
02
Launch engagement
Secure, closed-group platform. Advisors contribute on their own schedule over two to three weeks.
-
03
Senior moderation
Cogience partner moderates throughout - drawing in quiet voices, probing emerging themes, no junior layer.
-
04
Deliver outputs
Executive summary in 72 hours. Full insight report in two weeks. Structured exports for value dossiers and HTA submissions.
Tailored for rare diseases
Built around the decisions HTA bodies make.
The platform is most useful where in-person advisory boards are impractical: orphan drug expert pools are small and global, busy specialists engage in ten-minute gaps, and HTA bodies increasingly expect patient-relevant evidence.
Engagement design maps directly onto rare disease and orphan drug decision criteria for each market:
- NICE Highly Specialised Technologies
- NICE severity modifier
- CADTH rare disease review
- HAS orphan drug pathway & ASMR
- G-BA AMNOG with orphan provisions
- AIFA Innovation Committee
- PBAC Life Saving Drugs Programme
- US payer archetypes
Patient and caregiver input is a first-class workflow, not an add-on, matching the direction of travel across NICE, CADTH, HAS, and G-BA.
Capabilities
Everything the engagement needs, in one platform.
Global advisor panel
Payers, HTA evaluators, KOLs, policy experts, and patient advocacy leads across Europe, North America, APAC, LATAM, MEA.
Threaded async discussion
Moderator prompts with rich-text responses, file attachments, and per-advisor private response options.
Scheduled prompt release
Engagement window managed automatically: Day 1 / Day 3 / Day 6 / Day 10 cadence by default.
Mid-engagement insertion
New prompts added as themes emerge, without restarting the engagement or losing the thread.
AI-assisted moderation
Shallow-response detection, sentiment scoring, and AI-drafted summaries - always reviewed by senior moderators.
HTA template library
Pre-built question scaffolds for NICE HST, CADTH, HAS, AMNOG, LSDP and US payer archetypes.
Client-branded portal
Per-engagement URL, branding, and observer mode for client teams with configurable advisor anonymisation.
Insight traceability
Every insight links back to specific advisor responses and business questions - exportable to value dossiers, CRMs, or Veeva.
Security & compliance by design
Built for a heavily regulated industry.
These controls are designed into the platform architecture. Certifications and additional data-residency regions are on the roadmap.
Encryption
AES-256 at rest, TLS 1.3+ in transit.
Multi-factor authentication
For all users: moderators, advisors and clients.
Role-based access
Moderator, client admin, observer and advisor roles, scoped per engagement.
Tamper-resistant audit logs
Every post, edit, access, and attachment logged.
Daily backups
Tested restore, documented incident response, breach SLA.
Closed-group identification
EFPIA Annex 3 on every discussion, with full audit trail.
GDPR by design
Consent capture, right-to-be-forgotten workflow, DPAs, DPIA, SCCs.
Industry codes
ABPI, EFPIA, PhRMA, IFPMA built into engagement design.
Transfer-of-value reporting
US Sunshine Act, Loi Bertrand, DE/IT/ES, Disclosure UK.
Data residency
EU hosting at launch. Switzerland, UK and US East on the roadmap.
Subprocessor register
Single global list, publicly transparent.
Certifications roadmap
SOC 2 Type I & II, HIPAA BAA, annual third-party pen test.
Ready to scope an engagement?
Every engagement begins with a direct conversation with the senior practitioner who will lead it.
Book a 30-minute call